Annals of urologic oncology (AUO, Ann Urol Oncol, p-ISSN: 2617-7765, e-ISSN: 2617-7773), publishes the results of novel research in the laboratory and clinical settings, including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human urologic oncology with the overall goal of improving clinical care of patients with urologic tumours. It includes three main subjects: bladder, prostate and kidney cancer. In addition, adrenal tumor, testicular cancer, and carcinoma of penis are also considered for the journal subjects.
Indexing Google Scholar, ResearchGate, DOAJ
Current Issue Volume 7 Issue 3, 2024 >>
Editorial board
Editors-in-Chief:
Prostate cancer (PCa) is a malignancy originating from the epithelial cells of the prostate gland, strongly influenced by androgens, and is one of the ...
Maham Khan
REVIEW | 18 Oct 2024
Extirpative bladder surgery for bladder cancer requires urinary diversion which causes cosmetic and functional changes that affect a patient’s body im ...
Ava Saidian, Hannah G Hingtgen ... Amirali Salmasi
RESEARCH | 13 Oct 2024
Prostate cancer (PCa) is the most common malignancy in the urinary system. Research suggest that prostate cancer is often accompanied by gene mutation ...
Xuguang Guo
REVIEW | 04 Aug 2024
Sarcomatoid and/or rhabdoid dedifferentiation are rare histopathological findings which may be heterogeneous in renal cell carcinoma. Sarcomatoid ren ...
Sunil V. Jagtap, Shubham S. Jagtap ... Devika Borade
REVIEW | 27 Aug 2024
Bacillus Calmette-Guérin (BCG) is the standard treatment for patients with non-muscle invasive bladder cancer (NMIBC). Although this therapy has been ...
Anusha Gupta, Shiv Verma, Sanjay Gupta
REVIEW | 29 Aug 2024
Systemic treatment, commonly referred to as chemotherapy, is a fundamental approach for treating muscle-invasive bladder cancer (MIBC) and metastatic ...
Haijun Hu, Xianghui Wu
REVIEW | 09 Sep 2024